WHMC(600136)
Search documents
ST明诚(600136) - 公司关于股东所持部分股份被解除冻结、轮候冻结暨继续被冻结的公告
2025-06-13 09:45
证券代码:600136 证券简称:ST 明诚 公告编号:临 2025-030 号 武汉当代明诚文化体育集团股份有限公司 关于股东所持部分股份被解除冻结、轮候冻结暨 继续被冻结的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 当代集团本次共计 9 笔被解除冻结、轮候冻结,合计数量为 82,874,129 股,占公司总股本的 4.06%。本次解除轮候冻结中的 10,140,000 股自解除轮候 冻结起自动变更为冻结状态,占公司总股本比例的 0.50%。截至本公告日,当代 集团持有公司的 78,705,094 股股份仍全部被标记、冻结或轮候冻结,占公司总 股本的 3.86%。 武汉当代明诚文化体育集团股份有限公司(以下简称"公司")股东武 汉当代科技产业集团股份有限公司(以下简称"当代集团")持有公司 78,705,094 股,占公司总股本的 3.86%。 一、本次股份被解除冻结、轮候冻结的基本情况 近日,公司收到股东当代集团的告知函,获悉当代集团本次共计 9 笔被解除 冻结、轮候冻结,合计数量为 82,874 ...
ST明诚(600136) - 武汉当代明诚文化体育集团股份有限公司2024年年度股东大会会议资料
2025-06-13 09:15
2024 年年度股东大会会议资料 武汉当代明诚文化体育集团股份有限公司 2024 年年度股东大会会议资料 武 汉 二〇二五年六月 2024 年年度股东大会会议资料 目 录 | 序号 | | 议案名称 | 页码 | | --- | --- | --- | --- | | 1 | 2024 年度董事会工作报告 | | 1 | | 2 | 2024 年度监事会工作报告 | | 6 | | 3 | 2024 年度财务决算及 2025 | 年度财务预算报告 | 8 | | 4 | 2024 年度利润分配预案 | | 12 | | 5 | 2024 年年度报告及其摘要 | | 13 | | 6 | 2024 年度内部控制评价报告 | | 14 | | 7 | 2025 年度日常关联交易预计的议案 | | 22 | | 8 | 2025 年度担保预计的议案 | | 32 | | 9 | 2025 年度融资计划的议案 | | 39 | | 10 | 关于变更公司全称并修订《公司章程》的议案 | | 41 | 2024 年年度股东大会会议资料 议案 1: 武汉当代明诚文化体育集团股份有限公司 2024 年度董事会工作报告 各位 ...
ST明诚: 公司关于股东所持部分股份被解除冻结、轮候冻结暨继续被冻结的公告
Zheng Quan Zhi Xing· 2025-06-03 10:29
证券代码:600136 证券简称:ST 明诚 公告编号:临 2025-029 号 武汉当代明诚文化体育集团股份有限公司 关于股东所持部分股份被解除冻结、轮候冻结暨 继续被冻结的公告 | 股东名称 | 武汉当代科技产业集团股份有限公司 | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 本次解除冻结股份 | | | 522,972,083 | 股 | | | | 占其所持股份比例 | | | | 664.47% | | | | 占公司总股本比例 | | | | 25.63% | | | | 解除冻结时间 | 2025 | 年 | 5 | 月 | 29 | 日 | | 持股数量 | | 78,705,094 | | 股 | | | | 持股比例 | | | | | | | 3.86% 剩余被冻结股份数量 78,705,094 股 剩余被冻结股份数量占其所持股份比 例 100% 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: ? 武汉当代明诚文化体育集团 ...
ST明诚(600136) - 公司关于持股5%以上股东部分股份被拍卖流拍的公告
2025-06-03 10:02
证券代码:600136 证券简称:ST 明诚 公告编号:临 2025-028 号 武汉当代明诚文化体育集团股份有限公司 关于持股 5%以上股东部分股份被拍卖 流拍的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其 内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 本次拍卖标的为武汉当代明诚文化体育集团股份有限公司(以下简称"公司") 持股 5%以上股东(含其一致行动人)武汉当代科技产业集团股份有限公司(以下简称"当 代集团")所持公司的 21,840,000 股股份,占其所持公司股份总数的 27.74%,占公司总 股本的 1.07%。 本次拍卖标的因在规定时间内无人出价已流拍。 二、本次拍卖的进展情况 本次拍卖于 2025 年 5 月 30 日 17 时结束,经公司查询京东资产交易平台,显示本次 拍卖的标的因在规定时间内无人出价已流拍。 三、其他说明及风险提示 (一)本次被拍卖的标的后续是否再次被拍卖具有不确定性。公司将根据拍卖进展情 况,依法履行相应的信息披露义务。 (二)本次拍卖事项不会对公司经营管理产生重大不利影响,亦不会导致公司控股股 东和实际控制 ...
ST明诚(600136) - 公司关于股东所持部分股份被解除冻结、轮候冻结暨继续被冻结的公告
2025-06-03 10:00
证券代码:600136 证券简称:ST 明诚 公告编号:临 2025-029 号 武汉当代明诚文化体育集团股份有限公司 关于股东所持部分股份被解除冻结、轮候冻结暨 继续被冻结的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 武汉当代明诚文化体育集团股份有限公司(以下简称"公司")股东武 汉当代科技产业集团股份有限公司(以下简称"当代集团")持有公司 78,705,094 股,占公司总股本的 3.86%。 当代集团本次共计 25 笔被解除冻结、轮候冻结,合计数量为 522,972,083 股,占公司总股本的 25.63%。本次解除轮候冻结中的 5,599,519 股自解除轮候 冻结起自动变更为冻结状态,占公司总股本比例的 0.27%。截至本公告日,当代 集团持有公司的 78,705,094 股股份仍全部被标记、冻结或轮候冻结,占公司总 股本的 3.86%。 一、本次股份被解除冻结、轮候冻结的基本情况 近日,公司收到股东当代集团的告知函,获悉当代集团本次共计 25 笔被解 除冻结、轮候冻结,合计数量为 522 ...
5月21日晚间重要资讯一览
Zheng Quan Shi Bao Wang· 2025-05-21 15:42
Group 1 - The State Financial Supervision Administration and seven other departments issued measures to support financing for small and micro enterprises, emphasizing the establishment of a coordination mechanism for financing support [1] - The measures include conducting extensive visits to small and micro enterprises to assess their operational status and financing needs, facilitating direct access to bank credit [1] - There is a focus on addressing the operational difficulties faced by small and micro enterprises and encouraging support for key sectors such as foreign trade, private enterprises, technology, and consumption [1] Group 2 - In May 2025, a total of 130 domestic online games were approved by the National Press and Publication Administration [2] Group 3 - The State Council announced the removal of Wang Jianjun from the position of Vice Chairman of the China Securities Regulatory Commission [3] Group 4 - The Shanghai Municipal Government issued a plan to boost consumption, which includes measures to promote reasonable income growth and improve wage distribution mechanisms [4] - The plan aims to enhance the minimum wage adjustment mechanism and support the development of the rural economy and new business models [4] Group 5 - Shanghai is accelerating the introduction of childcare subsidies and maternity social security subsidies as part of its efforts to build a family-friendly society [5] - The city plans to explore increasing parental leave and spouse's paternity leave while enhancing the quality of public kindergartens [5] Group 6 - The Ministry of Foreign Affairs stated that China has the capability and confidence to handle external risks, including tariff wars, as evidenced by a 2.4% year-on-year increase in total goods import and export in the first four months of the year [6] - Exports grew by 7.5%, indicating strong international competitiveness despite high tariff barriers [6] Group 7 - The Ministry of Foreign Affairs expressed strong opposition to the EU's unilateral sanctions against Chinese companies, emphasizing the need for fair trade practices [8] - The ministry highlighted that normal business interactions between Chinese and Russian companies should not be disrupted by these sanctions [8] Group 8 - The Dalian Commodity Exchange announced trading arrangements for the Dragon Boat Festival period, with a market closure from May 31 to June 2, 2025, and a return to normal trading on June 3 [9] Group 9 - Heng Rui Pharmaceutical set the issuance price for its H-shares at HKD 44.05 per share [11] - Xinyuan Technology plans to issue H-shares and list on the Hong Kong Stock Exchange [11] - The company Guokai Microelectronics is planning a major asset restructuring, leading to a suspension of its stock from May 22 [11]
晚间公告丨5月21日这些公告有看头
第一财经· 2025-05-21 14:31
Key Points - Vanke A has signed a supplementary agreement with Shenzhen Metro Group for a loan of up to 4.2 billion yuan, with a pledge of up to 6 billion yuan in shares of its subsidiary, Wanwu Cloud [3] - Heng Rui Pharmaceutical has set the final price for its H-share issuance at 44.05 HKD per share, with plans to list on the Hong Kong Stock Exchange on May 23, 2025 [4] - Wan Dong Medical has elected Ma Chibing as the new chairman after Hu Ziqiang resigned from the position [5] - Tianqi Mould has confirmed that there are no undisclosed significant matters amid ongoing major asset restructuring [6] - Zhejiang Rongtai plans to invest 20 million yuan to establish a wholly-owned subsidiary focused on intelligent robotics [7] - ST Mingcheng intends to publicly transfer 45% of its subsidiary, Time Media, which will no longer be included in the consolidated financial statements [8] - Shanghai Xiba plans to purchase patent assets for 2 million yuan and 500,000 yuan, and establish subsidiaries to promote the commercialization of new technologies [9] - Jushen Co. has received a total of 95.7 million yuan in dividends from its six wholly-owned subsidiaries [10] - ST Asia Pacific has confirmed no undisclosed significant matters or ongoing major plans [11] - Tianrong Tianyu's controlling shareholder's agreement will not be renewed after its expiration [12] - Wangzi New Materials has stated that its energy storage capacitor business is minimal and will not significantly impact its performance [13] - Nanjing Port has clarified that its foreign trade container business does not have direct routes to the U.S. [14] - Jinlongyu has indicated that its solid-state battery business has not yet formed stable long-term revenue [15] - Tianzhihang's subsidiary plans to raise capital by introducing investors [16] - State Grid Information plans to acquire 100% of Yili Technology for 1.853 billion yuan, enhancing its revenue and profit [17] - ST Nongsang will remove its delisting risk warning starting May 23 [18] - Yipin Hong has stated that its innovative drug AR882 has not yet been launched and will not significantly impact recent performance [19] - Huanrui Century has announced a performance compensation plan requiring original shareholders to compensate 116 million shares [20] - Huaren Health plans to acquire stakes in three pharmaceutical chain companies for a total of 3.282 billion yuan [21][22] - Hongming Co. is planning to acquire 83% of Shenzhen Chisu for 1.51 billion yuan [23] - Aishida intends to acquire an additional 7% stake in its subsidiary Qianjiang Robot for 13.09 million yuan [24] - Dasheng Intelligent has signed a contract worth 11.5 million yuan for a high-efficiency machine room project [25] - Jinggu Co. has received a notice to supply wheels for a major global automaker, with expected sales of approximately 158 million USD over ten years [26] - Pingzhi Information has signed a framework agreement with China Mobile for antenna products worth up to 13.01 million yuan [27] - Shanghai Laishi's controlling shareholder plans to increase its stake by 250 million to 500 million yuan [28] - Qixia Construction's shareholder plans to reduce its stake by up to 3% [29] - Sichuan Gold's major shareholders plan to reduce their stakes by up to 5.5% [30] - Qingyun Technology's shareholders plan to reduce their stakes by up to 4.5% [31] - Rhein Biological's directors plan to reduce their stakes by up to 0.14% [32] - Qingmu Technology's shareholder plans to reduce its stake by up to 3% [33] - Sanrenxing's employee shareholding platform plans to reduce its stake by up to 3% [34][35] - Juzhi Technology's director plans to reduce his stake by up to 40,000 shares [36] - Jingwang Electronics' major shareholders plan to reduce their stakes by up to 2.99% [37] - Jujiao Co. plans to reduce its stake by up to 2.6% [38] - Xiyu Tourism's major shareholder plans to reduce its stake by up to 3% [39]
5月21日晚间重要公告一览
Xi Niu Cai Jing· 2025-05-21 10:14
Group 1 - Huiyu Pharmaceutical's subsidiary received drug registration certificate for Carboxymethyl Sodium Injection, which is used for treating bleeding diseases in various medical fields [1] - Baihe Co., Ltd. announced a plan for a director to reduce holdings by up to 424,000 shares, representing 0.6625% of the total share capital [1] - Kingood Co., Ltd. received a notification from a global leading automaker for a wheel project, expected to start mass production in 2026 with a lifecycle of 10 years [1][2] Group 2 - Wanhua Chemical plans to repurchase shares worth between 300 million and 500 million yuan, with a maximum repurchase price of 99.36 yuan per share [2] - Warner Pharmaceutical's subsidiary received approval for Acetylcysteine raw material drug, primarily used for treating respiratory diseases [3] - ST Mingcheng plans to publicly transfer 45% equity of its subsidiary, aiming to optimize asset structure [4] Group 3 - Qixia Construction announced a plan to reduce up to 31.5 million shares, accounting for 3% of total share capital [5][6] - Zhejiang Rongtai intends to invest 20 million yuan to establish a wholly-owned subsidiary focused on intelligent robotics [7] - Yuandong Biological received drug registration for Chloral Hydrate Enema, used for sedation and seizure control in children [9] Group 4 - Jiemai Technology's subsidiary signed a strategic cooperation agreement with a solid-state battery company to produce high-safety composite conductive materials [10] - Xianju Pharmaceutical received drug registration for Progesterone Soft Capsules, used for treating functional disorders due to luteal deficiency [11] - Lanhua Kecai's subsidiary reported a temporary production halt, with the resumption date yet to be determined [13] Group 5 - Sinopharm Modern's subsidiary received drug registration for Tocilizumab Tablets, used for treating rheumatoid arthritis and other conditions [15] - Shanghai Bank announced the resignation of its vice president due to organizational adjustments [17] - Shanghai Pharmaceutical's Ephedrine Injection passed the consistency evaluation for generic drugs [19] Group 6 - Rundu Co., Ltd. received drug registration for Amlodipine and Olmesartan Tablets, aimed at treating hypertension [21] - Zhong'an Technology announced that 61 million shares held by its controlling shareholder will be auctioned [23] - Shanghai Washba plans to purchase patent assets and establish two subsidiaries focused on hydrogen energy and solid-state battery technologies [25] Group 7 - Nuo Cheng Jianhua's new drug Tafasitamab received approval for treating relapsed/refractory diffuse large B-cell lymphoma [26] - Benli Technology plans to use up to 200 million yuan of idle funds for cash management and financial investments [28] - Taiji Co., Ltd. intends to use 60 million yuan of idle funds to purchase financial products [29] Group 8 - Haishi Co. announced that its innovative drug Anreke Fen Injection received drug registration for treating postoperative pain [32] - Yulong Co. will have its stock delisted on May 27, 2025, following a decision by the Shanghai Stock Exchange [36] - Weifu High-Tech plans to establish a joint venture with Shanghai Baolong Automotive Technology [38] Group 9 - Xichang Electric Power expects a net profit reduction of approximately 5.4 million yuan due to adjustments in the time-of-use electricity pricing mechanism [39] - Alter signed a contract worth 6.8 billion yen for the development and procurement of large truck EV kits [41] - Zhonglian Heavy Industry plans to acquire controlling stakes in its financing leasing subsidiary through public bidding [42] Group 10 - Sanyou Medical's executive plans to reduce holdings by up to 1.44% of the company's shares [43] - Hangyang Co. plans to establish a subsidiary for large modular cryogenic equipment manufacturing with an estimated investment of 557 million yuan [44] - FAW Fuwi received a notification for a dashboard project from a well-known new energy brand, with total sales expected to reach 1.06 billion yuan [45]
ST明诚(600136) - 武汉当代明诚文化体育集团股份有限公司拟股权转让所涉及的武汉当代时光传媒有限公司股东全部权益价值评估项目资产评估报告
2025-05-21 09:17
本资产评估报告依据中国资产评估准则编制 武汉当代明诚文化体育集团股份有限公司拟股权转让 所涉及的武汉当代时光传媒有限公司 股东全部权益价值评估项目 资产评估报告 湖北玖誉[2025]资评报字第 043 号 (全一册) 湖北到 百有限公司 户六日 中国资产评估协会 资产评估业务报告备案回执 | 报告编码: | 4242160001202500052 | | --- | --- | | 合同编号: | DDMC-T2-202504-007 | | 报告类型: | 法定评估业务资产评估报告 | | 报告文号: | 湖北玖誉[2025]资评报字第043号 | | 报告名称: | 武汉 当代明诚文化体育集团股份有限公司拟股权转让所涉及的武 | | | 汉当代时光传媒有限公司股东全部权益价值评估项目 | | 评估结论: | 6,058,004.66元 | | 评估报告日: | 2025年05月06日 | | 评估机构名称: | 湖北玖誉房地产评估有限公司 | | 签名人员: | 彭雨 薇 (资产评估师) 正式会员 编号: 42200036 | | | 朱元杰 (资产评估师) 正式会员 编号:42190071 | (可扫描 ...
ST明诚(600136) - 公司关于关联租赁的公告
2025-05-21 09:16
武汉当代明诚文化体育集团股份有限公司 关于关联租赁的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 证券代码:600136 证券简称:ST明诚 公告编号:临2025-026号 武汉当代明诚文化体育集团股份有限公司(以下简称"公司")全资子公 司湖北联影创艺文化传媒有限公司(以下简称"联影创艺")拟租赁湖北清能酒 店管理集团有限公司(以下简称"清能酒管")旗下湖北清江饭店用于营业性演 出。 清能酒管为公司关联方,本次交易构成关联交易。 本次交易不构成重大资产重组。 本次关联交易总金额约为562.25万元,未超过公司最近一期经审计净资产 的5%,因此无需提交股东大会审议。 一、关联交易基本情况 (一)关联交易简介 为加快公司全资子公司联影创艺的业务开展速度,强化其可持续发展能力, 联影创艺拟租赁清能酒管旗下湖北清江饭店用于营业性演出,租赁期六年,租赁 建筑面积2,590平方米,租金合计约为562.25万元。 (二)关联交易履行的审议程序 1、独立董事专门会议审议情况 2025年5月21日,公司召开了独立董事专 ...